drugset / Trial / NCT06013995
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate safety, drug levels and drug effects on cells and organs of the body, after receiving multiple increasing doses of BMS-986326 via intravenous (IV) infusion or subcutaneous (SC) injection, in participants with different forms of lupus.
Timeline
- Start
- 2023-09-21
- Primary completion
- 2026-04-14
- Completion
- 2026-04-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986326 | Unknown | — | Intravenous |